Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Melatonin vs Tranexamic Acid in Melasma
NCT07169383Phase 2Enrolling by invitation
- Start
- Jun 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in melasma. Started Jun 2025; status: enrolling by invitation.
02
Drugs
melatonin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07169383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07169383.